Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Viel KR et al. - The preliminary results suggest that mismatched factor VIII replacement therapy may be a risk factor for the development of anti–factor VIII alloantibodies.

Related Articles

Functional independence score in hemophilia: A cross-sectional study assessment of Mexican children
Pediatric Blood & Cancer, 10/08/09    Relevance Score: 88%

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A
Journal of Thrombosis and Haemostasis, 10/28/09    Relevance Score: 87%

The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis
Blood Coagulation & Fibrinolysis, 10/05/09    Relevance Score: 87%

Athletic Participation in Severe Hemophilia: Bleeding and Joint Outcomes in Children on Prophylaxis
Pediatrics, 11/02/09    Relevance Score: 85%

Kinetics of factor VIII:C inhibitors and treatment response in severe hemophilia A patients
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 82%

Today in Hematology/Oncology...keeping you current

Tobacco use, body mass and cancer mortality in Mumbai Cohort Study
Cancer Epidemiology, 12/08/09

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study
Cancer Epidemiology, 12/08/09

Intermediate-differentiated invasive (pT1 G2) penile cancer--oncological outcome and follow-up
Urologic Oncology: Seminars and Original Investigations, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address